| __timestamp | Amicus Therapeutics, Inc. | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 5579000000 |
| Thursday, January 1, 2015 | 76943000 | 5997000000 |
| Friday, January 1, 2016 | 104793000 | 5890000000 |
| Sunday, January 1, 2017 | 149310000 | 5757000000 |
| Monday, January 1, 2018 | 270902000 | 5932000000 |
| Tuesday, January 1, 2019 | 286378000 | 5958000000 |
| Wednesday, January 1, 2020 | 308443000 | 5991000000 |
| Friday, January 1, 2021 | 272049000 | 9736000000 |
| Saturday, January 1, 2022 | 276677000 | 9762000000 |
| Sunday, January 1, 2023 | 152381000 | 10935000000 |
| Monday, January 1, 2024 | 13583000000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC and Amicus Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, AstraZeneca's R&D expenses surged by approximately 96%, peaking at $10.9 billion in 2023. This reflects their aggressive strategy to maintain a competitive edge in the global market. In contrast, Amicus Therapeutics, a smaller player, increased its R&D spending by over 220% during the same period, reaching $308 million in 2020. Despite the disparity in absolute figures, Amicus's growth rate underscores its dedication to innovation, particularly in niche therapeutic areas. This comparison highlights the diverse strategies within the pharmaceutical industry, where both giants and emerging companies strive to lead in medical advancements.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and HUTCHMED (China) Limited
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.